Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Mitochondrial GTP Links Nutrient Sensing to β Cell Health, Mitochondrial Morphology, and Insulin Secretion Independent of OxPhos.

Jesinkey SR, Madiraju AK, Alves TC, Yarborough OH, Cardone RL, Zhao X, Parsaei Y, Nasiri AR, Butrico G, Liu X, Molina AJ, Rountree AM, Neal AS, Wolf DM, Sterpka J, Philbrick WM, Sweet IR, Shirihai OH, Kibbey RG.

Cell Rep. 2019 Jul 16;28(3):759-772.e10. doi: 10.1016/j.celrep.2019.06.058.

PMID:
31315053
2.

Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities.

Coppé JP, Mori M, Pan B, Yau C, Wolf DM, Ruiz-Saenz A, Brunen D, Prahallad A, Cornelissen-Steijger P, Kemper K, Posch C, Wang C, Dreyer CA, Krijgsman O, Lee PRE, Chen Z, Peeper DS, Moasser MM, Bernards R, van 't Veer LJ.

Nat Cell Biol. 2019 Jun;21(6):778-790. doi: 10.1038/s41556-019-0328-z. Epub 2019 Jun 3.

PMID:
31160710
3.

Synchronous detection of circulating tumor cells in blood and disseminated tumor cells in bone marrow predict adverse outcome in early breast cancer.

Magbanua MJM, Yau C, Wolf DM, Lee JS, Chattopadhyay A, Scott JH, Bowlby-Yoder E, Hwang ES, Alvarado M, Ewing CA, Delson A, Van't Veer LJ, Essermann L, Park JW.

Clin Cancer Res. 2019 May 29. pii: clincanres.3888.2018. doi: 10.1158/1078-0432.CCR-18-3888. [Epub ahead of print]

PMID:
31142502
4.

Implementing a Standardized Discussion Forum Rubric Across 3 Online Nursing Programs.

Fisher M, Robb M, Wolf DM, Slade J.

Nurse Educ. 2019 Jan 11. doi: 10.1097/NNE.0000000000000652. [Epub ahead of print] No abstract available.

PMID:
30640803
5.

Elamipretide Promotes Mitophagosome Formation and Prevents Its Reduction Induced by Nutrient Excess in INS1 β-cells.

Petcherski A, Trudeau KM, Wolf DM, Segawa M, Lee J, Taddeo EP, Deeney JT, Liesa M.

J Mol Biol. 2018 Dec 7;430(24):4823-4833. doi: 10.1016/j.jmb.2018.10.020. Epub 2018 Oct 30.

PMID:
30389435
6.

Initial B Cell Activation Induces Metabolic Reprogramming and Mitochondrial Remodeling.

Waters LR, Ahsan FM, Wolf DM, Shirihai O, Teitell MA.

iScience. 2018 Jul 27;5:99-109. doi: 10.1016/j.isci.2018.07.005. Epub 2018 Jul 10.

7.

Individual islet respirometry reveals functional diversity within the islet population of mice and human donors.

Taddeo EP, Stiles L, Sereda S, Ritou E, Wolf DM, Abdullah M, Swanson Z, Wilhelm J, Bellin M, McDonald P, Caradonna K, Neilson A, Liesa M, Shirihai OS.

Mol Metab. 2018 Oct;16:150-159. doi: 10.1016/j.molmet.2018.07.003. Epub 2018 Jul 25.

8.

A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.

Barry KC, Hsu J, Broz ML, Cueto FJ, Binnewies M, Combes AJ, Nelson AE, Loo K, Kumar R, Rosenblum MD, Alvarado MD, Wolf DM, Bogunovic D, Bhardwaj N, Daud AI, Ha PK, Ryan WR, Pollack JL, Samad B, Asthana S, Chan V, Krummel MF.

Nat Med. 2018 Aug;24(8):1178-1191. doi: 10.1038/s41591-018-0085-8. Epub 2018 Jun 25.

9.

Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.

Bidard FC, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, Naume B, Horiguchi J, Gisbert-Criado R, Sleijfer S, Toi M, Garcia-Saenz JA, Hartkopf A, Generali D, Rothé F, Smerage J, Muinelo-Romay L, Stebbing J, Viens P, Magbanua MJM, Hall CS, Engebraaten O, Takata D, Vidal-Martínez J, Onstenk W, Fujisawa N, Diaz-Rubio E, Taran FA, Cappelletti MR, Ignatiadis M, Proudhon C, Wolf DM, Bauldry JB, Borgen E, Nagaoka R, Carañana V, Kraan J, Maestro M, Brucker SY, Weber K, Reyal F, Amara D, Karhade MG, Mathiesen RR, Tokiniwa H, Llombart-Cussac A, Meddis A, Blanche P, d'Hollander K, Cottu P, Park JW, Loibl S, Latouche A, Pierga JY, Pantel K.

J Natl Cancer Inst. 2018 Jun 1;110(6):560-567. doi: 10.1093/jnci/djy018.

PMID:
29659933
10.

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.

Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, Omberg L, Wolf DM, Shriver CD, Thorsson V; Cancer Genome Atlas Research Network, Hu H.

Cell. 2018 Apr 5;173(2):400-416.e11. doi: 10.1016/j.cell.2018.02.052.

11.

Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, Shen R, Taylor AM, Cherniack AD, Thorsson V, Akbani R, Bowlby R, Wong CK, Wiznerowicz M, Sanchez-Vega F, Robertson AG, Schneider BG, Lawrence MS, Noushmehr H, Malta TM; Cancer Genome Atlas Network, Stuart JM, Benz CC, Laird PW.

Cell. 2018 Apr 5;173(2):291-304.e6. doi: 10.1016/j.cell.2018.03.022.

12.

Reducing Commercial Truck Driver BMI Through Motivational Interviewing and Self-Efficacy.

Wilson JL, Wolf DM, Olszewski KA.

Workplace Health Saf. 2018 Jun;66(6):270-275. doi: 10.1177/2165079918754585. Epub 2018 Feb 28.

PMID:
29486659
13.

Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance).

Magbanua MJM, Rugo HS, Wolf DM, Hauranieh L, Roy R, Pendyala P, Sosa EV, Scott JH, Lee JS, Pitcher B, Hyslop T, Barry WT, Isakoff SJ, Dickler M, Van't Veer L, Park JW.

Clin Cancer Res. 2018 Mar 15;24(6):1486-1499. doi: 10.1158/1078-0432.CCR-17-2312. Epub 2018 Jan 8.

14.

DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial.

Wolf DM, Yau C, Sanil A, Glas A, Petricoin E, Wulfkuhle J, Severson TM, Linn S, Brown-Swigart L, Hirst G, Buxton M, DeMichele A, Hylton N, Symmans F, Yee D, Paoloni M, Esserman L, Berry D, Rugo H, Olopade O, van 't Veer L.

NPJ Breast Cancer. 2017 Aug 25;3:31. doi: 10.1038/s41523-017-0025-7. eCollection 2017.

15.

Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.

Bartelink IH, Prideaux B, Krings G, Wilmes L, Lee PRE, Bo P, Hann B, Coppé JP, Heditsian D, Swigart-Brown L, Jones EF, Magnitsky S, Keizer RJ, de Vries N, Rosing H, Pawlowska N, Thomas S, Dhawan M, Aggarwal R, Munster PN, Esserman LJ, Ruan W, Wu AHB, Yee D, Dartois V, Savic RM, Wolf DM, van 't Veer L.

Breast Cancer Res. 2017 Sep 11;19(1):107. doi: 10.1186/s13058-017-0896-4.

16.

The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting.

Severson TM, Wolf DM, Yau C, Peeters J, Wehkam D, Schouten PC, Chin SF, Majewski IJ, Michaut M, Bosma A, Pereira B, Bismeijer T, Wessels L, Caldas C, Bernards R, Simon IM, Glas AM, Linn S, van 't Veer L.

Breast Cancer Res. 2017 Aug 25;19(1):99. doi: 10.1186/s13058-017-0861-2.

17.

Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.

Amara D, Wolf DM, van 't Veer L, Esserman L, Campbell M, Yau C.

Breast Cancer Res Treat. 2017 Jan;161(1):41-50. doi: 10.1007/s10549-016-4041-3. Epub 2016 Nov 4.

PMID:
27815749
18.

Critical Role for CD103(+)/CD141(+) Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma.

Roberts EW, Broz ML, Binnewies M, Headley MB, Nelson AE, Wolf DM, Kaisho T, Bogunovic D, Bhardwaj N, Krummel MF.

Cancer Cell. 2016 Aug 8;30(2):324-336. doi: 10.1016/j.ccell.2016.06.003. Epub 2016 Jul 14.

19.

An Atlas of the Human Kinome Reveals the Mutational Landscape Underlying Dysregulated Phosphorylation Cascades in Cancer.

Olow A, Chen Z, Niedner RH, Wolf DM, Yau C, Pankov A, Lee EP, Brown-Swigart L, van 't Veer LJ, Coppé JP.

Cancer Res. 2016 Apr 1;76(7):1733-45. doi: 10.1158/0008-5472.CAN-15-2325-T. Epub 2016 Feb 26.

20.

A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies.

Chien AJ, Cockerill A, Fancourt C, Schmidt E, Moasser MM, Rugo HS, Melisko ME, Ko AH, Kelley RK, Korn WM, Esserman LJ, van't Veer L, Yau C, Wolf DM, Munster PN.

Breast Cancer Res Treat. 2016 Feb;155(3):521-30. doi: 10.1007/s10549-016-3701-7. Epub 2016 Feb 13.

PMID:
26875185
21.

Boot Camp for Occupational Health Nurses: Understanding Social Media.

Wolf DM, Olszewski K.

Workplace Health Saf. 2015 Aug;63(8):362-7; quiz 368. doi: 10.1177/2165079915592747. Review.

PMID:
26240119
22.

Follow Me, Like Me, Tweet Me! Implementing Social Media Into Occupational Health.

Olszewski K, Wolf DM.

Workplace Health Saf. 2015 Jun;63(6):240-4. doi: 10.1177/2165079915580739. Epub 2015 Jun 18.

PMID:
26089112
23.

Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response.

Magbanua MJ, Wolf DM, Yau C, Davis SE, Crothers J, Au A, Haqq CM, Livasy C, Rugo HS; I-SPY 1 TRIAL Investigators, Esserman L, Park JW, van 't Veer LJ.

Breast Cancer Res. 2015 May 29;17:73. doi: 10.1186/s13058-015-0582-3.

24.

Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity.

Broz ML, Binnewies M, Boldajipour B, Nelson AE, Pollack JL, Erle DJ, Barczak A, Rosenblum MD, Daud A, Barber DL, Amigorena S, Van't Veer LJ, Sperling AI, Wolf DM, Krummel MF.

Cancer Cell. 2014 Dec 8;26(6):938. doi: 10.1016/j.ccell.2014.11.010. Epub 2014 Dec 8. No abstract available.

25.

Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity.

Broz ML, Binnewies M, Boldajipour B, Nelson AE, Pollack JL, Erle DJ, Barczak A, Rosenblum MD, Daud A, Barber DL, Amigorena S, Van't Veer LJ, Sperling AI, Wolf DM, Krummel MF.

Cancer Cell. 2014 Nov 10;26(5):638-52. doi: 10.1016/j.ccell.2014.09.007. Epub 2014 Oct 16.

26.

Expression profiling of circulating tumor cells in metastatic breast cancer.

Lang JE, Scott JH, Wolf DM, Novak P, Punj V, Magbanua MJ, Zhu W, Mineyev N, Haqq CM, Crothers JR, Esserman LJ, Tripathy D, van 't Veer L, Park JW.

Breast Cancer Res Treat. 2015 Jan;149(1):121-31. doi: 10.1007/s10549-014-3215-0. Epub 2014 Nov 29.

27.

Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.

Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, Leiserson MDM, Niu B, McLellan MD, Uzunangelov V, Zhang J, Kandoth C, Akbani R, Shen H, Omberg L, Chu A, Margolin AA, Van't Veer LJ, Lopez-Bigas N, Laird PW, Raphael BJ, Ding L, Robertson AG, Byers LA, Mills GB, Weinstein JN, Van Waes C, Chen Z, Collisson EA; Cancer Genome Atlas Research Network, Benz CC, Perou CM, Stuart JM.

Cell. 2014 Aug 14;158(4):929-944. doi: 10.1016/j.cell.2014.06.049. Epub 2014 Aug 7.

28.

Promoting health and safety virtually: key recommendations for occupational health nurses.

Wolf DM, Anton BB, Wenskovitch J.

Workplace Health Saf. 2014 Jul;62(7):302-6; quiz 307. doi: 10.3928/21650799-20140617-02.

PMID:
25000549
29.

Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity.

Wolf DM, Lenburg ME, Yau C, Boudreau A, van 't Veer LJ.

PLoS One. 2014 Feb 7;9(2):e88309. doi: 10.1371/journal.pone.0088309. eCollection 2014.

30.

A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences.

Mittempergher L, Saghatchian M, Wolf DM, Michiels S, Canisius S, Dessen P, Delaloge S, Lazar V, Benz SC, Tursz T, Bernards R, van't Veer LJ.

Mol Oncol. 2013 Oct;7(5):987-99. doi: 10.1016/j.molonc.2013.07.006. Epub 2013 Jul 17.

31.

Mentoring and coaching: a model guiding professional nurses to executive success.

Thompson R, Wolf DM, Sabatine JM.

J Nurs Adm. 2012 Nov;42(11):536-41. doi: 10.1097/NNA.0b013e31827144ea.

PMID:
23100006
32.

Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors.

Petrillo LA, Wolf DM, Kapoun AM, Wang NJ, Barczak A, Xiao Y, Korkaya H, Baehner F, Lewicki J, Wicha M, Park JW, Spellman PT, Gray JW, Van't Veer L, Esserman LJ.

Breast Cancer Res Treat. 2012 Oct;135(3):913-22. doi: 10.1007/s10549-012-2226-y. Epub 2012 Sep 2.

33.

Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib.

Daemen A, Wolf DM, Korkola JE, Griffith OL, Frankum JR, Brough R, Jakkula LR, Wang NJ, Natrajan R, Reis-Filho JS, Lord CJ, Ashworth A, Spellman PT, Gray JW, van't Veer LJ.

Breast Cancer Res Treat. 2012 Sep;135(2):505-17. doi: 10.1007/s10549-012-2188-0. Epub 2012 Aug 9.

34.

An open-label, randomized efficacy and safety trial of subcutaneous and intramuscular BT088 (Fovepta) human hepatitis B immunoglobulin in neonates of HBV-carrier mothers.

Buxmann H, Kamin W, Kriván G, Siklós P, Mendling W, Wartenberg-Demand A, Wolf DM, Schlösser RL.

J Perinat Med. 2012 Feb 1;40(4):433-8. doi: 10.1515/jpm-2011-0185.

PMID:
22752776
35.

Subtype and pathway specific responses to anticancer compounds in breast cancer.

Heiser LM, Sadanandam A, Kuo WL, Benz SC, Goldstein TC, Ng S, Gibb WJ, Wang NJ, Ziyad S, Tong F, Bayani N, Hu Z, Billig JI, Dueregger A, Lewis S, Jakkula L, Korkola JE, Durinck S, Pepin F, Guan Y, Purdom E, Neuvial P, Bengtsson H, Wood KW, Smith PG, Vassilev LT, Hennessy BT, Greshock J, Bachman KE, Hardwicke MA, Park JW, Marton LJ, Wolf DM, Collisson EA, Neve RM, Mills GB, Speed TP, Feiler HS, Wooster RF, Haussler D, Stuart JM, Gray JW, Spellman PT.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2724-9. doi: 10.1073/pnas.1018854108. Epub 2011 Oct 14.

36.

Clinical efficacy, safety and pharmacokinetic properties of the plasma-derived factor IX concentrate Haemonine in previously treated patients with severe haemophilia B.

Serban M, Skotnicki AB, Colovic M, Jinca C, Klukowska A, Laguna P, Wolf DM.

Haemophilia. 2012 Mar;18(2):175-81. doi: 10.1111/j.1365-2516.2011.02624.x. Epub 2011 Aug 3.

PMID:
21812863
37.

Nursing professional development specialists as change agents and innovators.

Wolf DM, Morgan J.

J Nurses Staff Dev. 2011 Mar-Apr;27(2):92-3. doi: 10.1097/NND.0b013e31820fed9f. No abstract available.

PMID:
21430481
38.
39.

Nurses using futuristic technology in today's healthcare setting.

Wolf DM, Kapadia A, Kintzel J, Anton BB.

Stud Health Technol Inform. 2009;146:59-63.

PMID:
19592809
40.

Complexity in bacterial cell-cell communication: quorum signal integration and subpopulation signaling in the Bacillus subtilis phosphorelay.

Bischofs IB, Hug JA, Liu AW, Wolf DM, Arkin AP.

Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6459-64. doi: 10.1073/pnas.0810878106. Epub 2009 Apr 20.

41.

Clinical decision support. How CDS tools impact patient care outcomes.

Anton BB, Schafer JJ, Micenko A, Wolf DM, DiNucci S, Donovan P, Jordan B.

J Healthc Inf Manag. 2009 Winter;23(1):39-45.

PMID:
19181200
42.

Impact factor and study design: the Academic Value of Published Research (AVaRes) score.

Wolf DM, Williamson PA.

Ann R Coll Surg Engl. 2009 Jan;91(1):71-3. doi: 10.1308/003588409X359222. Epub 2008 Nov 4.

43.

Effect of patient-centered care on patient satisfaction and quality of care.

Wolf DM, Lehman L, Quinlin R, Zullo T, Hoffman L.

J Nurs Care Qual. 2008 Oct-Dec;23(4):316-21. doi: 10.1097/01.NCQ.0000336672.02725.a5.

PMID:
18806645
44.

Modularity of stress response evolution.

Singh AH, Wolf DM, Wang P, Arkin AP.

Proc Natl Acad Sci U S A. 2008 May 27;105(21):7500-5. doi: 10.1073/pnas.0709764105. Epub 2008 May 21.

45.

Memory in microbes: quantifying history-dependent behavior in a bacterium.

Wolf DM, Fontaine-Bodin L, Bischofs I, Price G, Keasling J, Arkin AP.

PLoS One. 2008 Feb 27;3(2):e1700. doi: 10.1371/journal.pone.0001700.

46.

Patient first: a patient sensitivity tool for an electronic health record implementation.

Wolf DM, Hartman LM, Larue EM, Arndt I.

Comput Inform Nurs. 2007 Mar-Apr;25(2):112-7.

PMID:
17356333
47.
48.

Community hospital successfully implements eRecord and CPOE.

Wolf DM, Greenhouse PK, Diamond JN, Fera W, McCormick DL.

Comput Inform Nurs. 2006 Nov-Dec;24(6):307-16.

PMID:
17108749
49.
50.

Diversity in times of adversity: probabilistic strategies in microbial survival games.

Wolf DM, Vazirani VV, Arkin AP.

J Theor Biol. 2005 May 21;234(2):227-53. Epub 2005 Jan 24.

PMID:
15757681

Supplemental Content

Support Center